Qualitek Labs Ltd.
BBSE:QLL543.25
INR
+15.25
(+2.89%)
ISIN
INE0Q1R01012
Return %
Stock
S&P 500
1Y
26.19
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Antaryami Nayak
- Full Time Employees
- 677
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Address
- Noida India
- IPO Date
- Jan 25, 2024
- Website
- qualiteklab.com
- Similar Companies
- Business
- Qualitek Labs Limited is an India-based testing, inspection, certification, and homologation services provider delivering comprehensive quality assurance, material testing, and regulatory compliance solutions to industrial and commercial sectors. Founded in 2018 and headquartered in New Delhi with corporate operations based in Noida, Uttar Pradesh, the company serves clients across the automotive, electric vehicle, defense, aerospace, pharmaceuticals, food and agriculture, environmental, and metals and metallurgy industries. The company provides an extensive portfolio of specialized technical services categorized into core testing and assurance domains, comprising: automotive and mobility testing, including electric vehicle battery pack evaluations, powertrain validation, vibration and fatigue analysis, environmental climatic simulation, salt spray corrosion testing, ingress protection, interior trim flammability, and component homologation support; defense and aerospace testing, including qualification testing under JSS 55555 and military standard specifications; mechanical and metallurgical testing, including tensile strength, impact resistance, hardness, microstructural characterization, and failure analysis; chemical and analytical testing, including elemental composition analysis, hazardous substance identification, and RoHS/REACH compliance testing; electrical and electronics testing, including electromagnetic compatibility, electromagnetic interference, and electrical safety assessments; pharmaceutical and life sciences testing, covering active pharmaceutical ingredient analysis, raw material validation, microbial limit testing, and stability studies; food, agriculture, and water testing, encompassing pesticide residue analysis, nutritional profiling, heavy metal detection, and environmental water quality assessments; inspection and auditing services, including pre-shipment inspection, vendor assessment, factory audits, and Type A third-party inspection under ISO/IEC 17020:2012; and technical consultancy, consisting of reverse engineering, regulatory advisory, and product development validation. In recent corporate developments, Qualitek Labs completed its initial public offering and listed its equity shares on the BSE SME platform in January 2024 (Ticker: BSE: 544091 / QLL) to finance infrastructure expansion and working capital requirements. Following its public listing, the company executed strategic acquisitions to broaden its sectoral capabilities, including the acquisition of a 100% equity stake in Quality and Testing Infosolution Private Limited, a majority stake in Interstellar Testing Centre Private Limited, and a specialized food testing laboratory facility in Mumbai for INR 8.82 crore. Through its subsidiary Interstellar Testing Centre, the company secured a three-year contract from Indian Oil Corporation. Operationally, Qualitek Labs has expanded its testing infrastructure across key industrial hubs in India, maintaining facilities in Noida, Pune, Bhubaneswar, and a dedicated pharmaceutical laboratory in Baddi, Himachal Pradesh. In 2026, the company approved a fundraising initiative of INR 47 crore through a preferential issue of equity shares and convertible warrants to support ongoing laboratory capacity expansions, equipment modernizations, and strategic growth initiatives.